MYC overexpression downregulates antigen-presenting and costimulatory molecules on tumor cells, enabling them to avoid immune system recognition; hence, MYC overexpression disrupts physical interactions between T cells and cancerous/precancerous cells with negative consequences [105]. This evidence concerns the gene MYC and neoplasm.